Abstract
Posterior reversible encephalopathy syndrome (PRES) is a neurological disorder that can affect all age groups. It appears to have a higher incidence in the female population. Some common risk factors include hypertension, electrolyte abnormalities, sepsis, and chemotherapeutic medications such as Obinutuzumab. Our patient, who had chronic lymphocytic leukemia (CLL), presented with altered mental status. She was recently started on Obinutuzumab less than a week before this presentation. MRI findings were consistent with PRES, including diffuse vasogenic cerebral edema predominately throughout the bilateral parietal and occipital lobes associated with some edematous extension into the posterior part of bilateral frontal lobes. This case aims to highlight the importance of early diagnosis by appropriately identifying the MRI features of PRES to improve patient quality of life and decrease morbidity and mortality.
Recommended Citation
Atef, Bentolhoda; Abdelazeem, Basel; Qureshi, Khadija; and Ghatol, Abhijeet
(2023)
"Posterior Reversible Encephalopathy Syndrome Triggered by Obinutuzumab in a Patient With Chronic Lymphocytic Leukemia,"
Journal of Community Hospital Internal Medicine Perspectives: Vol. 13:
Iss.
4, Article 18.
DOI: 10.55729/2000-9666.1216
Available at:
https://scholarlycommons.gbmc.org/jchimp/vol13/iss4/18
